Products
Fees
Download
Promotions
Promotions
Welcome Rewards
Referral Program
US Pre-Market Options Trading
For Institutions
For Institutions
Corporate Services
Developers
Help
About
About
About Longbridge
License & Regulatory
Media Coverage
Join Us
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote List
Quote List
Allist
(688578.SH)
Last Updated 00:00:00
News
Financials
Overview
Allist released its performance for the first three quarters, with a net profit attributable to the parent company of 1.616 billion yuan, a year-on-year increase of 52.01%
Zhitong
·
10/29/2025 06:01
SH
688578
-0.35%
Zhitong
·
10/29/2025 06:01
SH
688578
-0.35%
Allist: The net profit for the third quarter was 565 million yuan, a year-on-year increase of 38.77%
Zhitong
·
10/28/2025 18:35
SH
688578
-0.35%
Zhitong
·
10/28/2025 18:35
SH
688578
-0.35%
Allist conducted a block trade today at a discount, with 488,700 shares traded and a transaction amount of 51.1327 million yuan
Zhitong
·
09/11/2025 17:29
SH
688578
-0.35%
Zhitong
·
09/11/2025 17:29
SH
688578
-0.35%
Allist today conducted a block trade of 520,000 shares at a discount, with a transaction amount of 54.5532 million yuan
Zhitong
·
09/02/2025 17:28
SH
688578
-0.35%
Zhitong
·
09/02/2025 17:28
SH
688578
-0.35%
Today, a total of 99 stocks had block trades, with a total transaction amount of 2.8 billion yuan
Zhitong
·
09/01/2025 17:39
SH
688578
-0.35%
SZ
002625
-2.56%
SH
603589
-0.23%
Zhitong
·
09/01/2025 17:39
SH
688578
-0.35%
SZ
002625
-2.56%
SH
603589
-0.23%
Allist today conducted a block trade at a discount, with 5.3165 million shares traded, totaling 566 million yuan
Zhitong
·
09/01/2025 17:28
SH
688578
-0.35%
Zhitong
·
09/01/2025 17:28
SH
688578
-0.35%
Buy back InnoCare Pharma and increase holdings in Allist, European-China Fund's Gran: The innovative drug industry chain is expected to continue driving industry growth
Wallstreetcn
·
08/30/2025 12:55
SH
688428
+5.55%
HK
09969
+2.01%
SH
688578
-0.35%
Wallstreetcn
·
08/30/2025 12:55
SH
688428
+5.55%
HK
09969
+2.01%
SH
688578
-0.35%
Winning a cancer-fighting pill, Nantong contractor rakes in 11 billion
Wallstreetcn
·
08/29/2025 10:10
SH
688578
-0.35%
Wallstreetcn
·
08/29/2025 10:10
SH
688578
-0.35%
Allist released its semi-annual performance, with a net profit attributable to the parent company of 1.051 billion yuan, a year-on-year increase of 60.22%
Zhitong
·
08/26/2025 17:14
SH
688578
-0.35%
Zhitong
·
08/26/2025 17:14
SH
688578
-0.35%
ABBISKO-B: The IND application for the oral PD-L1 inhibitor ABSK043 from ABBISKO Pharmaceuticals in combination with Allist's KRAS G12C inhibitor citric acid gorasib tablets for the treatment of NSCLC has been approved by CDE
Zhitong
·
08/20/2025 19:29
SH
688578
-0.35%
HK
02256
-0.50%
Zhitong
·
08/20/2025 19:29
SH
688578
-0.35%
HK
02256
-0.50%